Top Markets
Coin of the day
Serina Therapeutics, Inc. Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
Rank in Stocks #26470
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating... Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Share Price
$2.70
Market Cap
$40.42M
Change (1 day)
-1.28%
Change (1 year)
-48.17%
Country
US
Trade Serina Therapeutics, Inc. (SER)

Category

Stock split history for Serina Therapeutics, Inc. (SER)
Serina Therapeutics, Inc. stock (symbol: SER) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 20, 2026.
One SER share bought prior to Aug 20, 2026 would equal to 0 SER shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US